Interesterified Palm Olein (IEPalm) and Interesterified Stearic Acid-Rich Fat Blend (IEStear) Have No Adverse Effects on Insulin Resistance: A Randomized Control Trial

Overview

Journal Nutrients

Date 2018 Aug 22

PMID 30126103

Citations 4

Authors

Yen Teng Ng

Phooi Tee Voon

Tony Kock Wai Ng

Verna Kar Mun Lee

Miskandar Mat Sahri

Norhaizan Mohd Esa

Seng Huat Ong

Augustine Soon Hock Ong

Affiliations

Soon will be listed here.

Abstract

Chemically-interesterified (CIE) fats are -fat free and are increasingly being used as an alternative to hydrogenated oils for food manufacturing industries to optimize their products' characteristics and nutrient compositions. The metabolic effects of CIE fats on insulin activity, lipids, and adiposity in humans are not well established. We investigated the effects of CIE fats rich in palmitic (C16:0, IEPalm) and stearic (C18:0, IEStear) acids on insulin resistance, serum lipids, apolipoprotein concentrations, and adiposity, using C16:0-rich natural palm olein (NatPO) as the control. We designed a parallel, double-blind clinical trial. Three test fats were used to prepare daily snacks for consumption with a standard background diet over a period of 8 weeks by three groups of a total of 85 healthy, overweight adult volunteers. We measured the outcome variables at weeks 0, 6, and at the endpoint of 8. After 8 weeks, there was no significant difference in surrogate biomarkers of insulin resistance in any of the IE fat diets (IEPalm and IEStear) compared to the NatPO diet. The change in serum triacylglycerol concentrations was significantly lower with the IEStear diet, and the changes in serum leptin and body fat percentages were significantly lower in the NatPO-diet compared to the IEPalm diet. We conclude that diets containing C16:0 and C18:0-rich CIE fats do not affect markers of insulin resistance compared to a natural C16:0-rich fat (NatPO) diet. Higher amounts of saturated fatty acids (SFAs) and longer chain SFAs situated at the -1,3 position of the triacylglycerol (TAG) backbones resulted in less weight gain and lower changes in body fat percentage and leptin concentration to those observed in NatPO and IEStear.

Citing Articles

Ultra-processed foods: Processing versus formulation.

Levine A, Ubbink J Obes Sci Pract. 2023; 9(4):435-439.

PMID: 37546281 PMC: 10399516. DOI: 10.1002/osp4.657.

Balancing functional and health benefits of food products formulated with palm oil as oil sources.

Sulaiman N, Sintang M, Mantihal S, Zaini H, Munsu E, Mamat H Heliyon. 2022; 8(10):e11041.

PMID: 36303903 PMC: 9593283. DOI: 10.1016/j.heliyon.2022.e11041.

Impact of Replacement of Individual Dietary SFAs on Circulating Lipids and Other Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials in Humans.

Sellem L, Flourakis M, Jackson K, Joris P, Lumley J, Lohner S Adv Nutr. 2021; 13(4):1200-1225.

PMID: 34849532 PMC: 9340975. DOI: 10.1093/advances/nmab143.

Palmitic Acid Versus Stearic Acid: Effects of Interesterification and Intakes on Cardiometabolic Risk Markers - A Systematic Review.

van Rooijen M, Mensink R Nutrients. 2020; 12(3).

PMID: 32111040 PMC: 7146500. DOI: 10.3390/nu12030615.

References

Zock P, de Vries J, de Fouw N, Katan M . Positional distribution of fatty acids in dietary triglycerides: effects on fasting blood lipoprotein concentrations in humans. Am J Clin Nutr. 1995; 61(1):48-55. DOI: 10.1093/ajcn/61.1.48. View

Klok M, Jakobsdottir S, Drent M . The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 2007; 8(1):21-34. DOI: 10.1111/j.1467-789X.2006.00270.x. View

Berry S, Woodward R, Yeoh C, Miller G, Sanders T . Effect of interesterification of palmitic acid-rich triacylglycerol on postprandial lipid and factor VII response. Lipids. 2007; 42(4):315-23. DOI: 10.1007/s11745-007-3024-x. View

Tura A, Ludvik B, Nolan J, Pacini G, Thomaseth K . Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab. 2001; 281(5):E966-74. DOI: 10.1152/ajpendo.2001.281.5.E966. View

Sundram K, Karupaiah T, Hayes K . Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans. Nutr Metab (Lond). 2007; 4:3. PMC: 1783656. DOI: 10.1186/1743-7075-4-3. View

Christophe A, De Greyt W, Delanghe J, Huyghebaert A . Substituting enzymatically interesterified butter for native butter has no effect on lipemia or lipoproteinemia in Man. Ann Nutr Metab. 2000; 44(2):61-7. DOI: 10.1159/000012822. View

Filippou A, Teng K, Berry S, Sanders T . Palmitic acid in the sn-2 position of dietary triacylglycerols does not affect insulin secretion or glucose homeostasis in healthy men and women. Eur J Clin Nutr. 2014; 68(9):1036-41. PMC: 4155797. DOI: 10.1038/ejcn.2014.141. View

Patel N, Taveira T, Choudhary G, Whitlatch H, Wu W . Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults. J Am Heart Assoc. 2013; 1(6):e003152. PMC: 3540682. DOI: 10.1161/JAHA.112.003152. View

Lefevre M, Mensink R, Kris-Etherton P, Petersen B, Smith K, Flickinger B . Predicted changes in fatty acid intakes, plasma lipids, and cardiovascular disease risk following replacement of trans fatty acid-containing soybean oil with application-appropriate alternatives. Lipids. 2012; 47(10):951-62. PMC: 3449058. DOI: 10.1007/s11745-012-3705-y. View

10.

Kallio H, Schwab U, Mykkanen H, Kurvinen J, Savolainen M, Tahvonen R . Effects of palm oil and transesterified palm oil on chylomicron and VLDL triacylglycerol structures and postprandial lipid response. J Lipid Res. 2001; 42(10):1618-25. View

11.

Gouk S, Cheng S, Mok J, Ong A, Chuah C . Long-chain SFA at the sn-1, 3 positions of TAG reduce body fat deposition in C57BL/6 mice. Br J Nutr. 2013; 110(11):1987-95. DOI: 10.1017/S0007114513001475. View

12.

Sanders T, Filippou A, Berry S, Baumgartner S, Mensink R . Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am J Clin Nutr. 2011; 94(6):1433-41. DOI: 10.3945/ajcn.111.017459. View

13.

Mozaffarian D, Katan M, Ascherio A, Stampfer M, Willett W . Trans fatty acids and cardiovascular disease. N Engl J Med. 2006; 354(15):1601-13. DOI: 10.1056/NEJMra054035. View

14.

Mensink R, Sanders T, Baer D, Hayes K, Howles P, Marangoni A . The Increasing Use of Interesterified Lipids in the Food Supply and Their Effects on Health Parameters. Adv Nutr. 2016; 7(4):719-29. PMC: 4942855. DOI: 10.3945/an.115.009662. View

15.

Gerrior S, Juan W, Basiotis P . An easy approach to calculating estimated energy requirements. Prev Chronic Dis. 2006; 3(4):A129. PMC: 1784117. View

16.

Gebauer S, Psota T, Kris-Etherton P . The diversity of health effects of individual trans fatty acid isomers. Lipids. 2007; 42(9):787-99. DOI: 10.1007/s11745-007-3095-8. View

17.

Berry S, Miller G, Sanders T . The solid fat content of stearic acid-rich fats determines their postprandial effects. Am J Clin Nutr. 2007; 85(6):1486-94. DOI: 10.1093/ajcn/85.6.1486. View

18.

Schwab U, Maliranta H, Sarkkinen E, Savolainen M, Kesaniemi Y, Uusitupa M . Different effects of palmitic and stearic acid-enriched diets on serum lipids and lipoproteins and plasma cholesteryl ester transfer protein activity in healthy young women. Metabolism. 1996; 45(2):143-9. DOI: 10.1016/s0026-0495(96)90044-x. View

19.

Hayes K, Khosla P . Dietary fatty acid thresholds and cholesterolemia. FASEB J. 1992; 6(8):2600-7. DOI: 10.1096/fasebj.6.8.1592210. View

20.

Gouk S, Cheng S, Ong A, Chuah C . Stearic acids at sn-1, 3 positions of TAG are more efficient at limiting fat deposition than palmitic and oleic acids in C57BL/6 mice. Br J Nutr. 2013; 111(7):1174-80. DOI: 10.1017/S0007114513003668. View